Hi Batermere & Honeycomb, don't get anxious yet since we still have time for Q3 estimate.
Batermere wrote:" If you recall, Damaj did Preliminary Q1 and Q2 REVS Estimates the first week of April for Q1 and the first week of July for Q2."
The 2nd date is incorrect since I went back in time to verify the dates and here is what I found out:
Mon, Apr 02, 2018 (1st Week of April)
4:05 PM Innovus Pharmaceuticals Reports Record Annual Revenue for Fiscal 2017 of $8.8 Million, Preliminary Q1 2018 Revenue of $4.3 Million to $4.4 Million and Expects to Exit 2018 Profitable - Business Wire
Tue, Jul 17, 2018 (3rd Week of July)
6:00 AM Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue of $6.6 million to $6.8 million - Business Wire
Thank goodness, this still gives us hope that Dr. Damaj may come out with the Revenue Estimate for Q3 the coming week.
My guess for the Q3 is around $8 millions. GLTA. :)